scispace - formally typeset
R

Rosalind Ramsey-Goldman

Researcher at Northwestern University

Publications -  277
Citations -  25052

Rosalind Ramsey-Goldman is an academic researcher from Northwestern University. The author has contributed to research in topics: Lupus erythematosus & Population. The author has an hindex of 72, co-authored 256 publications receiving 21037 citations. Previous affiliations of Rosalind Ramsey-Goldman include Dresden University of Technology & Toronto Western Hospital.

Papers
More filters
Journal ArticleDOI

Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus

TL;DR: The data indicate that PON2 genetic variants significantly affect variation in serum PON activity and have modest effects on risk of lupus nephritis and SLE-related immunologic disorder.
Journal ArticleDOI

A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus.

Zubin Patel, +86 more
TL;DR: A plausible molecular mechanism for increased lupus risk at the STAT1-STAT4 locus is presented in which the risk allele of rs11889341, the most probable causal variant, leads to elevated STAT1 expression in B cells due to decreased repressor activity mediated by increased binding of HMGA1.
Journal ArticleDOI

Racial differences and income disparities are associated with poor outcomes in kidney transplant recipients with lupus nephritis.

TL;DR: Income levels were associated with the risk of graft loss and death in AF but not in non-AF recipients with LN, and there were significant associations of lower-income quintiles with higher risk for graft Loss and death among AF with Ln.
Journal ArticleDOI

Management of cardiovascular complications in systemic lupus erythematosus

TL;DR: The treatment and management recommendations for patients with SLE are based largely on published guidelines for other populations at high risk for CVD, including patients with systemic lupus erythematosus.
Journal ArticleDOI

Fatigue in Systemic Lupus Erythematosus and Rheumatoid Arthritis

TL;DR: Empirically based fatigue treatment guidelines are needed in both rheumatoid arthritis and systemic lupus erythematosus because of variability in the reliability and validity of fatigue measures.